The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...
As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...
TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the ...
Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.
Kenisha Kennedy, family nurse practitioner at Westchester Community Health Center, joined News 12 this morning to discuss what can you do to protect yourself from the flu, RSV and norovirus, and what ...
GlobalData on MSN15h
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trialWhilst vaccines exist for animals, none are commercially available for human use for the mosquito-borne virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback